Figure 3 — Male patients with TERT mutation may be more likely to benefit from immunotherapy, especially for melanoma

Research Paper|Volume 12, Issue 17|pp. 17288–17294

Male patients with TERT mutation may be more likely to benefit from immunotherapy, especially for melanoma

100%

Figure 3.The effect of TERT mutation on the efficacy of immunotherapy in melanoma database. (A) Kaplan-Meier survival analysis between TERT altered and unaltered group in the male cohort. The red curve represents TERT altered group, and the blue curve represents unaltered group. (B) Kaplan-Meier survival analysis between TERT altered and unaltered group in the female cohort. The red curve represents TERT altered group, and the blue curve represents unaltered group.